ABSTRACT
Following traumatic injuries of the central nervous system (CNS) a wound healing scar, resembling the molecular structure of a basement membrane and mainly composed of Collagen type IV and associated glycoproteins and proteoglycans, is formed. It is well known that CNS fibers poorly regenerate after traumatic injuries. In this article we summarize data showing that prevention of collagen scar formation enables severed axons in brain and spinal cord to regrow across the lesion site and to elongate in uninjured CNS tissue. We observed that regenerating fibers grow back to their former target where they develop chemical synapses, become remyelinated by resident oligodendrocytes and conduct action potentials.
Subject(s)
Axons , Central Nervous System , Regeneration/physiology , Wound Healing , 8-Bromo Cyclic Adenosine Monophosphate/metabolism , Animals , Axons/pathology , Axons/physiology , Axotomy , Basement Membrane/cytology , Basement Membrane/metabolism , Basement Membrane/pathology , Central Nervous System/anatomy & histology , Central Nervous System/injuries , Central Nervous System/pathology , Central Nervous System/physiology , Chelating Agents/metabolism , Collagen/metabolism , Peripheral Nervous System/anatomy & histology , Peripheral Nervous System/pathology , Peripheral Nervous System/physiologyABSTRACT
PURPOSE: The improvement of regeneration and functional recovery after peripheral nerve injury is a major challenge in neurosurgery. Although microsurgical techniques for nerve reconstruction have seen great advancements over the last years, the clinical outcome with patients is often unsatisfactory. The aim of the present study was to investigate if administration of the iron chelator Deferroxamine (DFO), can improve postoperative outcome in the rat median nerve reconstruction model. METHODS: After complete transection, the right median nerve was repaired by end-to-end neurorrhaphy. The suture site was wrapped by a 1-cm-long external jugular vein segment, either empty or filled with DFO-loaded lipid particles (Perineurin or with a vehicle (unloaded lipid particles) alone. Functional testing was carried out weekly by means of the grasping test. At the time of withdrawal, 12 weeks post-operatively, muscle tropism recovery was assessed by weighing flexor digitorum sublimis muscle that is innervated by the median nerve only. Before harvesting of the nerve specimens electrophysiological analyses were performed with measuring the latency, the threshold and the conduction velocity. Finally, the repaired nerves were withdrawn for immunocytochemistry with a neurofilament antibody and axon quantitative morphology. RESULTS: The comparison between the groups showed that intraoperative application of the DFO-loaded lipid particles at the neurorrhaphy site led to a significant increase in the density of regenerating axons as well as to an accelerated recovery of both muscle tropism and motor function. The electrophysiological results demonstrated a decrease of the threshold, a lower latency, and a higher conduction velocity in the Perineurin-treated animals. CONCLUSIONS: The results of the present study suggest that local administration of Perineurin might have a therapeutic potential for improving the postoperative outcome after microsurgical nerve reconstruction in patients.
Subject(s)
Deferoxamine/pharmacology , Median Neuropathy/physiopathology , Recovery of Function/drug effects , Siderophores/pharmacology , Analysis of Variance , Animals , Body Weight/drug effects , Deferoxamine/administration & dosage , Disease Models, Animal , Electric Stimulation/methods , Female , Lipids/administration & dosage , Lipids/pharmacology , Median Neuropathy/drug therapy , Median Neuropathy/pathology , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiopathology , Neurofilament Proteins/metabolism , Organ Size/drug effects , Rats , Rats, Wistar , Siderophores/administration & dosage , Time FactorsABSTRACT
Traumatic injury of the central nervous system results in formation of a collagenous basement membrane-rich fibrous scar in the lesion centre. Due to accumulation of numerous axon-growth inhibitory molecules the lesion scar is considered a major impediment for axon regeneration. Following transection of the dorsal corticospinal tract (CST) at thoracic level 8 in adult rats, transient suppression of collagenous scarring in the lesion zone by local application of a potent iron chelator and cyclic adenosine monophosphate resulted in the delay of fibrous scarring. Treated animals displayed long-distance growth of CST axons through the lesion area extending for up to 1.5-2 cm into the distal cord. In addition, the treatment showed a strong neuroprotective effect, rescuing cortical motoneurons projecting into the CST that normally die (30%) after thoracic axotomy. Further, anterogradely traced CST axons regenerated through both grey and white matter and developed terminal arborizations in grey matter regions. In contrast to controls, injured animals receiving treatment showed significant functional recovery in the open field, in the horizontal ladder and in CatWalk locomotor tasks. We conclude that the fibrous lesion scar plays a pivotal role as a growth barrier for regenerating axons in adult spinal cord and that a delay in fibrotic scarring by local inhibition of collagen biosynthesis and basement membrane deposition is a promising and unique therapeutic strategy for treating human spinal trauma.
Subject(s)
Cicatrix/prevention & control , Nerve Regeneration/physiology , Pyramidal Tracts/pathology , Recovery of Function , Somatosensory Cortex/physiopathology , Spinal Cord Injuries/pathology , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , 2,2'-Dipyridyl/analogs & derivatives , 2,2'-Dipyridyl/therapeutic use , 8-Bromo Cyclic Adenosine Monophosphate/therapeutic use , Animals , Antigens/metabolism , Axons/pathology , Axons/physiology , Behavior, Animal , Biotin/analogs & derivatives , Biotin/metabolism , Cell Count/methods , Cicatrix/etiology , Collagen Type IV/metabolism , Dextrans/metabolism , Female , Ferrous Compounds/therapeutic use , Functional Laterality , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , Motor Activity/drug effects , Motor Activity/physiology , Proteoglycans/metabolism , Rats , Rats, Wistar , Spinal Cord Injuries/therapy , Stilbamidines , Time FactorsABSTRACT
After injury of the adult mammalian CNS axonal regeneration across or around the lesion scar is negligible. Previously, we have shown that the lesion-induced basal membrane (BM) within the lesion center participates in a growth barrier for axon regeneration and that its reduction by means of pharmacological or immunochemical treatment is a prerequisite and sufficient condition for regrowing axons to cross the lesion site. The present study was designed to further investigate this observation by analyzing the effect of a delayed treatment on the regeneration of both subacutely and chronically lesioned axons.Adult rats underwent unilateral transection of the postcommissural fornix. At one to five days after transection one group of animals received a local injection of 2, 2'-dipyridyl (DPY), an inhibitor of collagen triple helix formation and synthesis. Another group received a second transection within the former lesion site followed by an immediate DPY-injection at five days or 4 weeks after transection. Six weeks after the last surgery BM deposition and axonal regeneration were analysed using immunocytochemical methods.A local injection of DPY clearly reduced the lesion-induced BM deposition when applied within the first 3 days after transection. Under these conditions regrowing axons still crossed the former impermeable lesion site and regenerated within their normal pathway up to their former target, the mammillary body. However, in late subacute (5 d) and chronic stages (4 w) the double transection+injection paradigm failed to reduce BM deposition and, in consequence, also to induce axonal regeneration.These results demonstrate the potential of the collagen IV-reducing strategy to promote axonal regeneration across the lesion scar not only in acute but also in early subacute traumatic injuries.